dc.contributor.author |
Kárász, Nóra |
|
dc.contributor.author |
Juhász, Orsolya |
|
dc.contributor.author |
Imrei, Marcell |
|
dc.contributor.author |
Garami, Miklós |
|
dc.date.accessioned |
2023-11-20T08:07:28Z |
|
dc.date.available |
2023-11-20T08:07:28Z |
|
dc.date.issued |
2023 |
|
dc.identifier.citation |
journalVolume=15;journalIssueNumber=21;journalTitle=NUTRIENTS;pagination=4571, pages: 14;journalAbbreviatedTitle=NUTRIENTS; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/9588 |
|
dc.identifier.uri |
doi:https://doi.org/10.3390/nu15214571 |
|
dc.description.abstract |
Background: Hypovitaminosis D is associated with oncogenesis, and the initial level of Vitamin D may play a role in determining long-term prognosis, relapse-free survival (RFS) and overall survival (OS). The purpose of our study was to follow up pediatric cancer patients for a long time in terms of their baseline Vitamin D level and disease outcomes. Methods: We collected data on the initial 25(OH)D concentration in 117 children and examined their RFS and OS using Kaplan–Meier curves. Results: The initial 25(OH)D mean value in the relapsed group was 20.35 ng/mL (SE: 2.05) and in children without relapse it was 26.14 ng/mL (SE: 1.13). Both the relapse-free and overall Kaplan–Meier curves showed a tendency for children with lower serum Vitamin D concentrations to experience cancer recurrence or fatal outcomes sooner than patients with normal serum levels. Conclusions: Our results indicated a possible correlation between higher pretreatment serum Vitamin D concentrations and improved overall and relapse-free survival. |
|
dc.format.extent |
4571-4571 |
|
dc.relation.ispartof |
urn:issn:2072-6643 |
|
dc.title |
Long-Term Prognosis in Relation to Vitamin D Status in Pediatric Solid Tumor Patients |
|
dc.type |
Journal Article |
|
dc.date.updated |
2023-10-30T09:14:42Z |
|
dc.language.rfc3066 |
en |
|
dc.rights.holder |
NULL |
|
dc.identifier.mtmt |
34225357 |
|
dc.contributor.institution |
Gyermekgyógyászati Klinika |
|